We are live on ! Find out more
RCYC

Richard C. Young & Co Portfolio holdings

AUM $1.36B
1-Year Est. Return 66.41%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+66.41%
3 Year Est. Return
+137.43%
5 Year Est. Return
+151.84%
10 Year Est. Return
+342.18%
AUM
$524M
AUM Growth
+$55.4M
Cap. Flow
+$13.9M
Cap. Flow %
2.66%
Top 10 Hldgs %
33.63%
Holding
76
New
7
Increased
46
Reduced
15
Closed
7

Top Buys

Rank Stock Value
1
NVS icon
Novartis
NVS
+$8.63M
2
MRK icon
Merck
MRK
+$8.58M
3
MDT icon
Medtronic
MDT
+$8.48M
4
SNY icon
Sanofi
SNY
+$8.3M
5
NVO
Novo Nordisk
NVO
+$8.25M

Sector Composition

Rank Sector Weight
1 Healthcare 17.71%
2 Industrials 12.75%
3 Consumer Staples 12.33%
4 Financials 12.11%
5 Technology 6.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HSY icon
51
Hershey
HSY
$37.2B
$4.14M 0.79%
36,045
+5,047
+16% +$550K
RTX icon
52
RTX Corp
RTX
$295B
$4.12M 0.79%
50,797
+1,992
+4% +$151K
CL icon
53
Colgate-Palmolive
CL
$74.2B
$3.73M 0.71%
54,387
+4,693
+9% +$303K
KR icon
54
Kroger
KR
$36.3B
$3.52M 0.67%
142,904
+10,026
+8% +$275K
EMR icon
55
Emerson Electric
EMR
$85B
$3.07M 0.59%
44,846
+2,060
+5% +$135K
UNP icon
56
Union Pacific
UNP
$175B
$2.77M 0.53%
16,539
+2,483
+18% +$400K
SJM icon
57
J.M. Smucker
SJM
$13.2B
$2.73M 0.52%
23,420
+1,201
+5% +$126K
VYM icon
58
Vanguard High Dividend Yield ETF
VYM
$81.9B
$2.62M 0.5%
30,584
-805
-3% -$67.2K
PEP icon
59
PepsiCo
PEP
$195B
$2.35M 0.45%
19,159
-155
-0.8% -$17.7K
SIVR icon
60
abrdn Physical Silver Shares ETF
SIVR
$3.97B
$2.12M 0.4%
144,290
-2,708
-2% -$41K
HEP
61
DELISTED
Holly Energy Partners, L.P.
HEP
$1.84M 0.35%
68,169
-4,052
-6% -$118K
CLX icon
62
Clorox
CLX
$12.1B
$1.09M 0.21%
6,779
+5,481
+422% +$850K
VEU icon
63
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
$892K 0.17%
17,792
-536
-3% -$26.2K
VHT icon
64
Vanguard Health Care ETF
VHT
$18.6B
$618K 0.12%
3,587
-158,396
-98% -$26.8M
EPD icon
65
Enterprise Products Partners
EPD
$83.6B
$536K 0.1%
18,407
+3,065
+20% +$85.6K
AMLP icon
66
Alerian MLP ETF
AMLP
$12.9B
$521K 0.1%
10,388
+198
+2% +$9.71K
MMP
67
DELISTED
Magellan Midstream Partners, L.P.
MMP
$440K 0.08%
7,261
+1,455
+25% +$87.9K
BDX icon
68
Becton Dickinson
BDX
$45.8B
$335K 0.06%
1,376
+105
+8% +$24.8K
VIG icon
69
Vanguard Dividend Appreciation ETF
VIG
$113B
$224K 0.04%
2,039
-132
-6% -$13.9K
BTI icon
70
British American Tobacco
BTI
$134B
-47,061
Closed -$1.5M
EWD icon
71
iShares MSCI Sweden ETF
EWD
$536M
-49,379
Closed -$1.39M
FHLC icon
72
Fidelity MSCI Health Care Index ETF
FHLC
$3.37B
-826,090
Closed -$34.1M
GIS icon
73
General Mills
GIS
$20.1B
-19,557
Closed -$762K
IVV icon
74
iShares Core S&P 500 ETF
IVV
$871B
-18,215
Closed -$4.58M
IYE icon
75
iShares US Energy ETF
IYE
$1.69B
-77,577
Closed -$2.42M

Similar funds

Richard C. Young & Co's Q1 2019 Portfolio in Review

As of Q1 2019, Richard C. Young & Co held 76 positions worth $524M, up 12% from $468M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Richard C. Young & Co's Q1 2019 filing shows 7 new, 46 increased, 15 reduced and 7 closed positions. Its largest new stake was Novartis: 107,520 shares worth $9.26M. The largest sale was Fidelity MSCI Health Care Index ETF, an estimated $34.1M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 6.8% a quarter earlier, followed by Industrials and Consumer Staples.

  • Richard C. Young & Co's largest Q1 2019 buy was Novartis: 107,520 shares worth $9.26M.
  • Richard C. Young & Co added most to JP Morgan Alerian MLP Index ETN 5/24/24 in Q1 2019, an estimated $5.24M increase.
  • Richard C. Young & Co's biggest Q1 2019 reduction was Vanguard Health Care ETF, cutting an estimated $26.8M.
  • Richard C. Young & Co fully exited Fidelity MSCI Health Care Index ETF in Q1 2019, selling an estimated $34.1M.
  • Richard C. Young & Co's ten largest holdings make up 34% of its $524M portfolio in Q1 2019.
  • Richard C. Young & Co opened 7 new positions and closed 7 in Q1 2019.
  • Richard C. Young & Co's portfolio value rose 12% quarter-over-quarter to $524M.

Based on Richard C. Young & Co's 13F filing for Q1 2019, filed 9 May 2019.